Fortress Biotech, Inc. Notes Payable, Current
Fortress Biotech, Inc. (FBIO) had Notes Payable, Current of $5.00 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-13
- 2026-06-30: Notes Payable, Current $5.00M.
- 2026-03-31: Notes Payable, Current $2.50M.
- 2021-09-30: Notes Payable, Current $10.45M.
- 2020-12-31: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.00M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.50M 10-Q · filed 2026-05-14 | |
| 2021-09-30 | $10.45M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $16.80M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $11.40M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $7.22M 10-K/A · filed 2021-04-09 | $6.00M 10-Q · filed 2020-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-16 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $6.20M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $6.06M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $4.61M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $3.19M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.80M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |